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Abstract
Genome-wide association studies (GWAS) have identified that frequent polymorphisms in
ARID5B and IKZF1, two genes involved in lymphoid differentiation, increase the risk of child-
hood acute lymphoblastic leukemia (ALL). These findings markedly modified the current
field of research on the etiology of ALL. In this new context, the present exploratory study in-
vestigated the possible interactions between these at-risk alleles and the non-genetic sus-
pected ALL risk factors that were of sufficient prevalence in the French ESCALE study:
maternal use of home insecticides during pregnancy, preconception paternal smoking, and
some proxies for early immune modulation, i.e. breastfeeding, history of common infections
before age one year, and birth order. The analyses were based on 434 ALL cases and 442
controls of European origin, drawn from the nationwide population-based case-control
study ESCALE. Information on non-genetic factors was obtained by standardized tele-
phone interview. Interactions between rs10740055 in ARID5B or rs4132601 in IKZF1 and
each of the suspected non-genetic factors were tested, with the SNPs coded as counts of
minor alleles (trend variable). Statistical interactions were observed between rs4132601
and maternal insecticide use (p = 0.012), breastfeeding p = 0.017) and repeated early com-
mon infections (p = 0.0070), with allelic odds ratios (OR) which were only increased among
the children not exposed to insecticides (OR = 1.8, 95%CI: 1.3, 2.4), those who had been
breastfed (OR = 1.8, 95%CI: 1.3, 2.5) and those who had had repeated early common
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infections (OR = 2.4, 95%CI: 1.5, 3.8). The allelic ORs were close to one among children ex-
posed to insecticides, who had not been breastfed and who had had no or few common in-
fections. Repeated early common infections interacted with rs10740055 (p = 0.018) in the
case-only design. Further studies are needed to evaluate whether these observations of a
modification of the effect of the at-risk alleles by non-genetic factors are chance findings or
reflect true underlying mechanisms.
Introduction
Acute lymphoblastic leukemia [ALL] accounts for 80% of all childhood leukemia and for ap-
proximately one quarter of all childhood neoplasms in developed countries [1]. Until recently,
only Down’s syndrome, a few inheritable predisposing diseases and high-dose ionizing radia-
tion were known to increase the risk of ALL [2,3]. Genome-wide association studies (GWAS)
have revealed common Single Nucleotide Polymorphisms (SNP) associated with childhood
ALL risk [4–12]. The two loci associated with the greater ALL risk are in the AT-rich interac-
tive domain 5b gene (ARID5B, chromosomal region 10q21.2) and Ikaros family zinc finger 1
gene (IKZF1, chromosomal region 7p12.21). IKZF1 codes for a zinc finger transcription factor,
Ikaros, which is a key regulator of hematopoiesis. In particular, Ikaros is required for the devel-
opment of the earliest B-cell progenitors and at later stages for V(D)J recombination and B-cell
receptor expression [13,14]. Ikaros also acts as a tumor suppressor [15] and genetic alteration
of IKZF1 in leukemia cells is associated with a poor outcome in B-cell-progenitor ALL [16,17].
ARID5B is a member of the AT-rich interaction domain family of transcription factors that
plays an important role in embryogenesis and growth regulation [18]. The potential role of
ARID5B in immune response and lymphoid lineage differentiation has been less investigated
than for IKZF1. A role is supported by data from homozygous knockout mice that had immune
abnormalities and reduced numbers of B-cell progenitors [19].
The discovery of some ALL susceptibility loci calls for revisiting the suspected environmen-
tal risk factors for childhood ALL in light of the possible interactions those factors may have
with the variant alleles of ARID5B and IKZF1. The relationships between ALL and the expo-
sures may vary depending on ARID5B and IKZF1 polymorphisms and, conversely, the genetic
effects may be modified by environmental exposures. Indeed, growing evidence suggests that
environmental factors may cause diseases by modifying the expression of genes involved in key
cell functions, potentially through epigenetic deregulation [20–27]. Modeling their combined
effect may enable insights into the underlying biologic processes and the potential implication
of the environmental factors in ALL risk [28]. Several exposures are candidate risk factors for
childhood ALL: pesticides, low dose ionizing radiation, extremely low frequency electromag-
netic fields, benzene exposure, paternal smoking, absence of folic acid supplementation, infec-
tions transmitted through population mixing, a lack of early exposure to infectious agents, and
absence of breastfeeding [2,3].
The exploratory study reported herein investigated the potential interactions between poly-
morphisms rs10740055 of ARID5B, and rs4132601 of IKZF1, and the non-genetic suspected
ALL risk factors that were of sufficient prevalence in the ESCALE case-control study, for power
reasons: maternal use of home insecticides during pregnancy, preconception paternal smoking,
and some proxies for early immune modulation, i.e breastfeeding, history of repeated common
infections before age one year, and birth order [29–31].
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Materials and Methods
Case and control ascertainment
The ESCALE study is a population-based case-control study designed to assess the role of sev-
eral environmental and genetic factors in childhood cancer, including ALL [29–31]. The ALL
cases were children diagnosed with ALL between January 1, 2003, and December 31, 2004, as
defined by the registration criteria of the National registry of childhood hematopoietic malig-
nancies (RNHE). To be eligible, children were to be less than 15 years old and residing in
France at the time of diagnosis. Children were not eligible if they had been adopted, or if their
biological mother had died (n = 8), did not speak French (n = 19), had a serious psychiatric dis-
order (n = 12), or could not be interviewed for ethical reason because the child was in palliative
care (n = 2) or had died (n = 17). Among the 714 eligible ALL cases, 648 cases (91%) had par-
ticipated in the ESCALE study. Information on leukemia subtype and cytogenetic characteris-
tics was subsequently obtained from the RNHE information system.
The population controls, children free from cancer, were contemporaneously selected in
2003–2004, using a quota sampling method. A base of 60,000 phone numbers representative of
telephone subscribers was randomly extracted from the telephone directory (S1 Fig.). Then,
controls were recruited using gender and age quotas in sixteen strata (boys and girls from the
age strata 0–1, 2, 3, 4, 5–6, 7–8, 9–11 and 12–14 years) reflecting the expected distribution of all
the cancer cases included in the ESCALE study, based on rates from the RNHE [32] and the
Regional Childhood Cancer Registries [33]. Additional quotas were applied in order to make
the number of children less than 15 years old living in the household similar to that of the
French population, conditionally on age. Children who had been adopted, or whose biological
mother had died, did not speak French, or had a serious psychiatric disorder were not eligible.
Finally, 1681 of the 2360 eligible controls (71%) were enrolled in the ESCALE study.
A specimen was requested from each subject, and consisted in a blood sample for the cases,
and a saliva sample collected using a swab brush for the controls. After obtaining parental con-
sent, biological samples were taken from 619 (96%) of the 648 included ALL cases and 810
(48%) of the 1681 included controls, and 513 ALL cases and 570 controls had sufficient DNA
for genotyping (S1 Table).
Data collection
The mothers were interviewed by telephone, using the same standardized questionnaire for
cases and controls. The mothers were asked for socio-demographic information, child and
family medical history, and details on the child’s environment and lifestyle, birth characteristics
and infancy care. The mothers were also asked whether they had used products against insects
at home during pregnancy [30], if the father had ever smoked and the year he quitted [29], if
their child had been breastfed, and if the child had had none, 1 to 3, or four or more infectious
episodes for each of the following sites before age one year: tonsillitis, otitis, upper respiratory
tract infections, gastroenteritis, bronchiolitis and other lower respiratory tract infections, and
urinary tract infections [31]. A history of repeated early common infections was defined as 4 or
more episodes of infection of at least one given site or 1–3 episodes of infection of at least 4
sites in infancy [31].
Genotyping
The cases were genotyped on Illumina 370K-Quad BeadChips and the controls for 4,868 candi-
date SNPs on Illumina Infinium iSelect custom Beadchips (IntegraGen). Both beadchips in-
cluded SNPs from at-risk loci revealed in the first GWAS on ALL, in ARID5B and IKZF1 [4,5].
ARID5B, IKZF1, Non-Genetic Factors and Childhood ALL
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Quality control excluded 109 controls with an individual call rate less than 95% and 36 ALL
cases with an individual call rate less than 97%, low or high heterozygosity or discrepancies be-
tween stated gender and sexual chromosomes [6]. Six cases were excluded because they had
Down’s syndrome. Mean individual call rates were 99.9% for the cases and 98.5% for the con-
trols. The SNPs of interest did not deviate from the Hardy–Weinberg equilibrium in the
control sample.
The analyses were restricted to the 434 cases and 442 controls who had at least two Europe-
an-born grandparents, given that this criterion proved to be a good proxy to identify children
of European-descent in the present study [6]. The cases consisted in 10 pro-B ALL, 355 com-
mon B-cell ALL, 19 mature B-cell ALL, 40 T-cell ALL and 10 unspecified ALL (S1 Table).
Eighty-two common B-cell ALL cases were ETV6-RUNX positive and 157 were hyperdiploid
( 47 chromosomes).
Statistical analysis
The present analysis focused on rs4132601 for IKZF1 and, on rs10740055 for ARID5B, as these
SNPs were the most significantly associated with ALL in the ESCALE genotyped sample [6].
We selected the suspected non-genetic factors associated with ALL in our previous analyses,
and to which at least 30% of the control population were exposed. The factors included pater-
nal smoking since the year prior to the child’s birth [29], breastfeeding, repeated early common
infections and birth order (2 and more versus 1) [31], and maternal use of home insecticides
during pregnancy which was the pesticide exposure the most associated with acute leukemia in
the ESCALE study [30]. The analyses addressing common infections were restricted to the chil-
dren aged one year or more (398 controls and 426 ALL).
Odds ratios (OR) and their 95% confidence intervals (CI) were estimated using uncondi-
tional logistic regression models including the child’s age and gender, and parental socio-pro-
fessional category. ORs were calculated for each stratum of the variables combining each
polymorphism with each of the 5 non-genetic factors of interest. Interaction odds ratios (IOR)
between the polymorphism and the exposure of interest were estimated by both case-control
and case-only analyses, with the SNPs coded as counts of minor alleles (trend variable), and
tested under the multiplicative model. The IORs that could be detected with a power of 80%
and a two-tailed 5% level of significance were equal to 1.5 and 1.8 for the case-only and the
case-control design, respectively, assuming a minor allele frequency of 30%, an allelic OR of
1.5, an exposure prevalence of 30% and an OR of association between ALL and the exposure of
1.5.
The research was conducted in accordance with the principles of the Declaration of Helsinki
(World Medical Association, 2004) and complied with all applicable international regulatory
requirements. In particular, the study was reviewed and approved by the French National Insti-
tute of Health and Medical Research ethics committee and the Direction Générale de la Santé
institutional review board before the study began (DGS No. 2003/0259). Written informed
consent was obtained from the parents of the children enrolled in the study.
All regression analyses were conducted in SAS version 9.3 and minimal detectable IORs
were estimated using Quanto version 1.2.4 [34].
Results
Table 1 reports the associations previously observed between childhood ALL and the polymor-
phisms rs4132601 in IKZF1 and rs10740055 in ARID5B in the ESCALE study. The table also
shows the associations with maternal use of home insecticides during pregnancy, preconcep-
tion paternal smoking, birth order, breastfeeding and repeated early common infections
ARID5B, IKZF1, Non-Genetic Factors and Childhood ALL
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observed both in the genotyped subsample used for the present analysis and in the whole
ESCALE sample [29–31], with similar results.
The combined variables and the joint effects are shown in Table 2.
The more marked interactions were observed between rs4132601 and maternal insecticide
use (IOR = 0.5, 95%CI: 0.3–0.9, p = 0.012), breastfeeding (IOR = 1.7, 95%CI: 1.1–2.7,
p = 0.017) and repeated early common infections (IOR = 2.0, 95%CI: 1.2–3.4, p = 0.0070) in
Table 1. Association between childhood acute lymphoblastic leukemia (ALL), rs10740055 (ARID5B), rs4132601 (IKZF1), and the non-genetic fac-
tors of interest, in the ESCALE study, France 2003–2004.
ESCALE sample of genotyped European-descent children Whole ESCALE sample
(1681 controls and 648
ALL)Controls ALL Reference
N = 442 N = 434 ORa 95%CI ORa 95%CI
ARID5B (rs10740055) [6]
AA 106 67 Ref.
AC vs. AA 218 182 1.4 0.9, 2.0
CC vs. AA 118 185 2.5 1.7, 3.7***
C allele (allelic OR) MAF = 0.51 MAF = 0.64 1.6 1.3, 1.9***
IKZF1 (rs4132601) [6]
TT 211 175 Ref.
TG vs. TT 167 202 1.4 1.0, 1.8
GG vs. TT 37 57 1.9 1.1, 3.0*
missing 27 0
G allele (allelic OR) MAF = 0.29 MAF = 0.36 1.4 1.1, 1.7**
Maternal use of home insecticides during pregnancy [30]
No 283 222 Ref. Ref.
Yes 149 185 1.6 1.2, 2.2*** 1.7 1.4, 2.1***
missing 10 27
Preconception paternal smoking [29]
No 238 191 Ref. Ref.
Yes 196 229 1.3 1.0, 1.7 1.4 1.1, 1.7*
missing 8 14
Breastfeeding [31]
No 191 225 Ref. Ref.
Yes 251 209 0.8 0.6, 1.1 1.0 0.8, 1.2
Repeated early common infectionsb
No 246 288 Ref. Ref. [31]
Yes 127 123 0.8 0.6, 1.1 0.8 0.6, 0.9*
missing 25 15
Birth order [31]
First born 181 223 Ref. Ref.
Second born and over 261 211 0.5 0.4, 0.7** 0.7 0.6, 0.8**
ALL: acute lymphoblastic leukemia; CI: conﬁdence interval; MAF: minor allele frequency; OR: odds ratio; SNP: single nucleotide polymorphism
*:p<0.05;
**: p<0.01;
***: p<0.001
a OR and 95%CI estimated by unconditional logistic models including age and gender, and for non-genetic factors, parental socio-professional category.
b Restriction to children  1 year old
doi:10.1371/journal.pone.0121348.t001
ARID5B, IKZF1, Non-Genetic Factors and Childhood ALL
PLOSONE | DOI:10.1371/journal.pone.0121348 March 25, 2015 5 / 16
the case-control design (Table 3). The magnitudes of the interactions were similar using the
case-only design (Table 3).
The allelic ORs were only increased among the subjects not exposed to the suspected non-
genetic factor, i.e. the children whose mother did not use home insecticides during pregnancy
(allelic OR = 1.8, 95%CI: 1.3, 2.4), those who had been breastfed (allelic OR = 1.8, 95%CI: 1.3,
2.5) and those who had had repeated common infections in their first year of life (allelic
OR = 2.4, 95%CI: 1.5, 3.8) (Table 4). On the opposite, the relationship between ALL and the G
allele of rs4132601 was not present among the subjects exposed to the non-genetic factors, i.e.
the children whose mother used home insecticides during pregnancy (allelic OR = 1.0, 95%CI:
0.7, 1.5), those who had not been breastfed (allelic OR = 1.0, 95%CI: 0.8, 1.4) and those who
Table 2. Joint associations between childhood acute lymphoblastic leukemia (ALL) and the variables combining the non-genetic factors of inter-
est with rs10740055 (ARID5B) and rs4132601 (IKZF1) polymorphisms. The analyses addressing common infections were restricted to the children
aged one year or more (398 controls and 426 ALL), while the analyses addressing the other exposures were based on the whole sample (442 con-
trols and 434 ALL).
rs10740055 (ARID5B) rs4132601 (IKZF1)
Co/ALL ORa 95%CI Co/ALL ORa 95%CI Co/ALL ORa 95%CI Co/ALL ORa 95%CI
Maternal use of home insecticides during pregnancy Maternal use of home insecticides during pregnancy
No Yes No Yes
AA 69/33 1.0 Ref. 35/30 2.5 1.2, 5.0* TT 141/79 1.0 Ref. 65/85 2.4 1.5, 3.8***
AC 142/92 1.7 1.0, 2.9 70/80 2.9 1.6, 5.1*** TG 107/108 1.7 1.1, 2.6* 58/82 2.3 1.4, 3.7***
CC 72/97 3.4 1.9, 5.6*** 44/75 3.8 2.2, 6.9*** GG 19/35 3.4 1.7, 6.7*** 16/18 2.4 1.1, 5.3*
Preconception paternal smoking Preconception paternal smoking
No Yes No Yes
AA 56/34 1.0 Ref. 50/33 1.0 0.5, 2.0 TT 109/77 1.0 Ref. 96/92 1.1 0.7, 1.9
AC 115/81 1.3 0.8, 2.3 99/93 1.5 0.9, 2.7* TG 92/86 1.2 0.8, 1.9 73/110 1.7 1.1, 2.7*
CC 67/76 1.9 1.1, 3.4** 47/103 3.3 1.8, 5.9*** GG 19/28 2.3 1.2, 4.7* 18/27 2.0 1.0, 4.3*
Breastfeeding Breastfeeding
No Yes No Yes
AA 46/35 1.0 Ref. 60/32 0.9 0.5, 1.8 TT 87/101 1.0 Ref. 124/74 0.6 0.4, 1.0*
AC 98/88 1.4 0.8, 2.6 120/94 1.4 0.8, 2.4 TG 71/99 1.1 0.7, 1.8 96/103 1.0 0.6, 1.5
CC 47/102 3.0 1.6, 5.4*** 71/83 2.0 1.1, 3.6 GG 21/25 1.1 0.5, 2.1 16/32 2.3 1.1, 4.8*
Repeated early common infectionsb Repeated early common infectionsb
No Yes No Yes
AA 56/40 1.0 Ref. 37/24 0.9 0.5, 1.9 TT 113/126 1.0 Ref. 68/44 0.6 0.3, 0.9*
AC 123/111 1.3 0.8, 2.3 57/57 1.6 0.9, 2.9 TG 97/131 1.1 0.7, 1.6* 41/59 1.1 0.7, 1.9
CC 67/137 3.1 1.8, 5.3*** 33/42 1.7 0.9, 3.3 GG 22/31 1.2 0.6, 2.3 7/20 3.1 1.2, 8.0*
Birth order Birth order
1 2 1 2
AA 35/34 1.0 Ref. 71/33 0.5 0.3, 1.0* TT 77/88 1.0 Ref. 134/87 0.5 0.3, 0.8*
AC 98/93 1.2 0.7, 2.2 120/89 0.8 0.4, 1.5 TG 74/105 1.1 0.7, 1.8 93/97 0.7 0.4, 1.1
CC 48/96 2.7 1.4, 5.1** 70/89 1.1 0.6, 2.1 GG 18/30 1.7 0.8, 3.5 19/27 1.1 0.5, 2.2
ALL: acute lymphoblastic leukemia; CI: conﬁdence interval; Co: controls; OR: odds ratio; SNP: Single nucleotide polymorphism.
*: P<0.05;
**: P<0.01;
***: P<0.001
a OR and 95% CI estimated by unconditional logistic models including gender and age and parental socio-professional category.
b Restriction to children  1 year old
doi:10.1371/journal.pone.0121348.t002
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had had no or few common infections in their first year of life (allelic OR = 1.1, 95%CI: 0.8,
1.5) (Table 4). Similar differences in the effect of rs4132601 by the non-genetic factors were ob-
served for the most frequent ALL subtypes, i.e., common B-cell ALL, hyperdiploid common B-
cell ALL and ETV6-RUNX1 common B-cell ALL (Table 4).
Regarding ARID5B, the at-risk loci of rs10740055 also interacted with maternal insecticide
use, although not significantly. A negative interaction was observed with repeated early com-
mon infections (IOR = 0.7, 95%CI: 0.5–0.9, p = 0.018) in the case-only design (Table 5).
However, the tests were no longer significant when the Bonferroni correction for multiple
testing was applied (10 tests for 2 SNPs and 5 non-genetic factors; corrected alpha
risk = 0.005).
Discussion
In recent years some IKZF1 and ARID5B SNPs have been shown to be clearly associated with
childhood ALL. The present study showed that the at-risk allele of IKZF1 interacted negatively
with maternal use of home insecticides during pregnancy, and positively with factors related to
early immune modulation, breastfeeding and history of repeated early common infections.
There was no interaction with preconception paternal smoking.
However, chance findings cannot be ruled out as the study was exploratory with respect to
the interaction between the at-risk alleles and the non-genetic suspected risk factors. We have
limited multiple testing by focusing only on the 2 loci the most significantly associated with
ALL in the present study and the literature [4–12], and on the 5 non-genetic suspected ALL
risk factors that were of sufficient prevalence in the ESCALE case-control study. Therefore, the
other ALL risk loci identified by the GWAS, in CEBPE, CDKN2A, GATA3 and PIP4K2A, were
not investigated. Larger consortium-based studies are needed to comprehensively investigate
Table 4. Associations between childhood acute lymphoblastic leukemia (ALL) and rs4132601 (IKZF1) polymorphisms by non-genetic factors: alle-
lic OR in the whole sample and by ALLmajor subtypes, in the ESCALE study, France 2003–2004.
Maternal use of home
insecticides during pregnancy
Breastfeeding Repeated early common
infectionsb
No Yes Yes No Yes No
ORa 95%CI ORa 95%
CI
p int ORa 95%CI ORa 95%
CI
p int ORa IC95% ORa 95%
CI
p int
Rs4132601 (IKZF1)—OR per G allele
Whole sample
(n = 442 ALL)
1.8 1.3,
2.4***
1.0 0.7,
1.5
0.012 1.8 1.3,
2.5***
1.0 0.8,
1.4
0.017 2.4 1.5,
3.8***
1.1 0.8,
1.5
0.0070
B-com ALL
(n = 355)
1.7 1.3,
2.4***
0.9 0.6,
1.4
0.007 1.7 1.2, 2.4** 1.0 0.7,
1.4
0.03 2.3 1.4,
3.7***
1.0 0.8,
1.4
0.0078
Hyperdiploidy B-com
ALL (n = 157)
2.2 1.4,
3.4***
1.3 0.8,
2.2
0.07 2.2 1.4, 3.6** 1.3 0.8,
2.0
0.10 3.2 1.7,
6.0***
1.3 0.9,
2.0
0.026
ETV6-RUNX
positive B-com ALL
(n = 82)
1.7 1.0, 2.8 1.0 0.5,
1.8
0.18 1.9 1.1, 3.5* 1.0 0.6,
1.7
0.13 2.3 1.0, 5.1* 1.1 0.7,
1.7
0.10
ALL: acute lymphoblastic leukemia; B-com ALL: common B-cell ALL; CI: conﬁdence interval; OR: odds ratio; p int: p for interaction
*:p<0.05;
**: p<0.01;
***: p<0.001
a Allelic OR and 95% CI estimated by unconditional logistic models adjusted for gender, age and parental socio-professional category.
b children  1 year old
doi:10.1371/journal.pone.0121348.t004
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the interactions between each of the ALL susceptibility polymorphisms and non-genetic sus-
pected risk factors.
There was a substantial number of losses in the present study, related to non-participation,
refusal in providing genetic material, and insufficient amount of DNA, leading to the potential
for selection bias. Employment in the most qualified category ‘Intellectual and scientific jobs,
managers and intermediate professions’ was significantly more frequent in the parents of the
genotyped controls (56%) than in those of the other non-genotyped Caucasian controls (39%),
but significantly less frequent in the parents of the genotyped cases (34%) than in those of the
other non-genotyped Caucasian cases (45%). However, the frequency of the at risk alleles of
rs4132601 and rs10740055, differed only slightly according to whether the parents’ belonged to
the most qualified professional category, among both the controls and the cases. This, and the
fact that the associations of ALL with the non-genetic factors were similar in the genotyped
and non-genotyped children, suggest no or little effect of the loss of subjects on the estimation
of the interactions.
The cases and controls were genotyped separately using different methods, but the geno-
types obtained with the pangenomic and customized BeadChips were shown to be fully con-
cordant in a sample of 96 cases genotyped using both platforms [6]. Past exposures may not be
remembered perfectly by the mothers and some misclassifications inherent in the retrospective
design of the study could not be prevented. The potential for recall bias is likely to be greater
for a history of common infections and the use of pesticides during pregnancy, which are spo-
radic events, than for breastfeeding, paternal smoking or birth order. In particular, underre-
porting of medically diagnosed infections has been reported [35–37], and, in the United
Kingdom Childhood Cancer Study, an inverse association was observed between ALL and a
history of clinically diagnosed infections as reported by the mothers, but a positive association
was observed when relying on information from medical records [37,38]. In addition, studies
based on medical records or health claims databases reported null [39,40] or positive associa-
tions [41–43] between a history of clinically diagnosed infection and ALL, suggesting that chil-
dren who develop leukemia are more likely to have had clinically diagnosed infections in
infancy. The present study reported an inverse association between ALL and maternal report
of repeated common infections, medically diagnosed or not, considered as a surrogate for fre-
quent exposure to infectious agents. The influence of case/control status on that recall, and the
direction of the bias remain difficult to predict. However, with regard to the specific goal of the
present analyses, the exposure misclassifications are not expected to differ according to the
polymorphisms of interest and are not likely to have resulted in strong bias in the estimates of
the interactions.
To our knowledge, the interactions between the genetic variants identified by the GWAS
and some non-genetic factors have been investigated in only two previous studies. Linabery
et al. reported no interaction between some ARID5B and IKZF1 SNPs and some selected demo-
graphic factors, birth weight and maternal age, using a case-only design [44]. In a recent Aus-
tralian study, there was an evidence of interaction between rs4132601 risk genotype at IKZF1
and paternal preconception smoking (p = 0.05) and maternal use of folic acid (p = 0.04) [12].
In the present study, we did not observe an interaction with paternal smoking, and the power
was too limited for investigating interaction with folic acid supplementation, whose prevalence
was low in France during the study period [45]. Interestingly, in the present study and in the
Australian study, the increase in ALL risk in carriers of the G allele of IKZF1 rs4132601 was
not observed in the event of exposure to the suspected risk factors (or in the absence of expo-
sure to the suspected protective factor). Biologically plausible explanations for our observations
are lacking and further studies are needed to replicate (or not replicate) our observations. One
possible explanation may be the modification of IKZF1 expression by the environment, as
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growing evidence suggests that environmental factors, including pesticides and breastfeeding,
may modify the expression of genes involved in key cell functions, in particular through epige-
netic deregulation [20–27]. To our knowledge, no experimental study has yet investigated the
possibility that exposure to pesticides or a lack of early immune stimulation may reduce the ex-
pression of IKZF1 or other genes involved in lymphoid differentiation, or that the impact of
the non-genetic factors may differ depending on the gene polymorphisms. The decrease in the
expression of one or several genes involved in a given cell function, following exposure to an
environmental factor, might possibly result in the same effect as carrying a specific polymor-
phism associated with lower expression of the genes, potentially leading to a negative interac-
tion. Statistical interactions on a multiplicative scale might also be observed if environmental
factors and genetic factors would lead to leukemia through different tumorigenic pathways.
In conclusion, this study suggests the possibility of a negative interaction between ALL sus-
ceptibility locus in IKZF1 and prenatal insecticide exposure, and of positive interactions be-
tween the at-risk allele and breastfeeding and history of repeated early common infections.
Further studies are needed to evaluate whether these observations are chance findings or reflect
true underlying mechanisms.
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